Literature DB >> 2307295

Operation of Randle's cycle in patients with NIDDM.

S Bevilacqua1, G Buzzigoli, R Bonadonna, L S Brandi, M Oleggini, C Boni, M Geloni, E Ferrannini.   

Abstract

It has been suggested that the insulin resistance of non-insulin-dependent diabetes mellitus (NIDDM) may be caused by substrate competition between glucose and free fatty acids (FFAs) (Randle's cycle). We measured substrate oxidation and energy metabolism in 10 nonobese untreated NIDDM patients with fasting glucose levels of 7-8 mM with indirect calorimetry in the basal state and during an isoglycemic-hyperinsulinemic (approximately 100 mU/L) clamp without (control) and with a concomitant infusion (approximately 0.35 mmol/min) of Intralipid, a triglyceride emulsion. In the control study, fasting rates of total glucose turnover [( 3-3H]glucose) and glucose and lipid oxidation (9.4 +/- 1.4, 7.3 +/- 1.3, and 3.0 +/- 0.4 mumol.kg-1.min-1, respectively) were comparable with those of nondiabetic individuals. After insulin administration, lipid oxidation was normally suppressed (to 1.3 +/- 0.3 mumol.kg-1.min-1, P less than 0.01), as were the circulating levels of FFA, glycerol, and beta-hydroxybutyrate, whereas glucose oxidation doubled (14.1 +/- 1.8 mumol.kg-1.min-1, P less than 0.01). Because glycemia was clamped at 7.5 mM, endogenous glucose production (EGP) was completely suppressed, and total glucose disposal was stimulated (to 25.7 +/- 5.2 mumol.kg-1.min-1, P less than 0.01 vs. baseline), but glucose clearance (3.6 +/- 0.8 ml.kg-1.min-1) was 30% reduced compared with normal. With concomitant lipid infusion, FFA, glycerol, and beta-hydroxybutyrate all rose during the clamp; correspondingly, lipid oxidation was maintained at fasting rates (3.6 +/- 0.2 mumol.kg-1.min-1, P less than 0.01 vs. control).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307295     DOI: 10.2337/diab.39.3.383

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

Review 1.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.

Authors:  C Magnan; M Gilbert; B B Kahn
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

Review 3.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.

Authors:  P M Piatti; L D Monti; S N Davis; M Conti; M D Brown; G Pozza; K G Alberti
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 5.  Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

6.  Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors:  S Nielsen; O Schmitz; N Møller; N Pørksen; I C Klausen; K G Alberti; C E Mogensen
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

Authors:  D E Kelley; M Mokan; J A Simoneau; L J Mandarino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Eriksson; C Saloranta; E Widén; A Ekstrand; A Franssila-Kallunki; C Schalin; L Groop
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

9.  Effects of fat on insulin-stimulated carbohydrate metabolism in normal men.

Authors:  G Boden; F Jadali; J White; Y Liang; M Mozzoli; X Chen; E Coleman; C Smith
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Authors:  E Widén; A Ekstrand; C Saloranta; A Franssila-Kallunki; J Eriksson; C Schalin-Jäntti; L Groop
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.